Hot Pharma Stocks / Ideen / Blockbuster

    KBLB

    Kraig Biocraft Laboratories Announces That Henry Wendt Has Joined Its Business Advisory Board

    Renowned Fortune 500 CEO Joins Kraig Advisory Board


    LANSING, MI, Nov 09, 2010 (MARKETWIRE via COMTEX) -- Kraig Biocraft Laboratories, Inc. (pinksheets:KBLB) announced today that Henry Wendt, the renowned former head of SmithKline Beecham, has joined the Company's Board of Advisors.


    Wendt is the former CEO and Chairman of SmithKline Beecham, one of the world's largest and most successful corporations. He has an unparalleled track record for fostering and managing corporate growth through mergers and acquisitions, as well as through organic growth and global marketing. In fact, he is generally recognized as the principal architect of the successful merger which created SmithKline Beecham.


    "Henry Wendt is one of the top CEOs on the planet, with a proven Fortune 500 track record," said Kraig Biocraft Laboratories CEO, Kim K. Thompson. "In addition to his groundbreaking leadership at SmithKline Beecham, he literally wrote the book on successful strategies for corporate growth in the global marketplace. Mr. Wendt's book Global Embrace: Corporate Challenges in a Transnational World is, in my opinion, a 'must read' for corporate executives. We are very fortunate and excited to have him on our team. I know that, as a member of our advisory board, his insight and advice will be invaluable, as we grow and commercialize our revolutionary technologies."

    Hot Pharma Stocks / Ideen / Blockbuster

    sharewatch wrote:

    Quote
    Bin bei Celsion rein.

    2011 und 20102 gibt es hier einige interessante Termine:

    http://www.celsion.com/pipeline.cfm


    sieht interessant aus für 2011. sie haben ein SPA mit der FDA, die Studie fürs Phase 3 Medi sollte bis Mitte 2011 fertig sein, falls positiv könnten sie die NDA bis Ende 2011 einreichen und mitte 2012 dürfte ein PDUFA Datum festgelegt werden. bist aber einbisschen früh rein..? Preisziel habe ich im Moment bei 8$.


    hier noch die infos:


    [Blocked Image: http://img14.imageshack.us/img14/489/unbenanntcg.th.png]

    Hot Pharma Stocks / Ideen / Blockbuster

    erste Posi CYCC 1.50$ :) genommen.

    werde später noch etwas dazu schreiben wenn ich den CYCC thread gefunden habe.


    OXGN 0.28$ sieht geil aus. ob sie wohl diesmal die spielchen sein lassen? könnt ja sein das die shorts auf long wechseln? das wär ja... :lol:

    Hot Pharma Stocks / Ideen / Blockbuster

    UNIVEC, Inc.

    (Public, PINK:UNVC)


    hmm ist hier was nachhaltiges im busch?


    Univec, Inc. (Univec), is an integrated licensing, manufacturing, and marketing company operating two divisions dedicated to providing safer health products to patients and caregivers worldwide. The Company’s syringe division develops, licenses and markets auto-disable and safety syringes worldwide. The physician and pharmaceutical services division assists pharmaceutical companies in marketing, fulfillment and tracking drug samples via an online system connecting pharmacies and managed payment providers. The Company also manufactures and markets sliding sheath syringes designed to protect patients and healthcare workers from needle stick injuries, in compliance with the federal needlestick safety and prevention act of the United States government.

    SNSS

    Sunesis Pharmaceuticals, Inc. Announces Grant Of Patent


    SOUTH SAN FRANCISCO, CA, Nov 15, 2010 (MARKETWIRE via COMTEX) -- Sunesis Pharmaceuticals, Inc. /quotes/comstock/15*!snss/quotes/nls/snss (SNSS 0.34, +0.02, +6.35%) today announced that the United States Patent and Trademark Office (USPTO) has granted U.S. Patent No. 7,829,577, claiming the Company's pharmaceutical compositions of lead drug candidate vosaroxin. This patent is scheduled to expire on March 14, 2025, and could be eligible for patent term extension beyond this date. Corresponding patent applications are pending in major markets throughout the world including Europe, Japan, Australia and Canada.


    "This patent is an important new addition to our intellectual property estate, as it covers the formulation currently used in our clinical trials," stated Daniel Swisher, Chief Executive Officer of Sunesis. "Vosaroxin's extended patent life to 2025 increases not only the value of our AML franchise but also provides sufficient time for lifecycle evaluation of vosaroxin in other indications. We are pursuing a sophisticated and deliberate strategy to extend exclusive coverage in the vosaroxin patent estate beyond 2025. In addition to our granted patents, we have filed patent applications covering additional formulations, combination uses, dosing, manufacturing processes and composition of matter claims. We look forward to the successful prosecution of these patent applications in multiple territories around the world."


    http://www.marketwatch.com/sto…1-15?reflink=MW_news_stmp

    Hot Pharma Stocks / Ideen / Blockbuster

    Vagnum wrote:

    Quote
    in at OXGN 0.25$

    lotto play.


    sie bringen neue fundamentale daten heraus nächste woche, werde nacher etwas dazu schreiben.


    lg


    Hallo Vagnum - Kannst Du mir sagen wesshalb OXGN trotz PIII Pipeline nur mit 20Mio MK ist?

    Hot Pharma Stocks / Ideen / Blockbuster

    Aurum wrote:

    Quote

    Vagnum wrote:


    Hallo Vagnum - Kannst Du mir sagen wesshalb OXGN trotz PIII Pipeline nur mit 20Mio MK ist?


    weiss ich nicht genau. ist halt ne kleine Bude die gerne verwässert. sie killen jeden run indem sie aktien herausschütten. vielleicht liegts daran. mal sehn obs diesmal auch so kommt. es steht ein schlüssel event an.

    Hot Pharma Stocks / Ideen / Blockbuster

    sharewatch wrote:

    Quote
    In @ASTM 3.50


    Aastrom Biosciences scheint ne Interessante Bude im Bereich Zellforschung zu sein.


    Du hast aber gesehen das die gerade eine Dilution durchgegeben haben?

    Hot Pharma Stocks / Ideen / Blockbuster

    Aurum


    Die Verwässerung ist bereits am Freitag bekannt geworden. ASTM hat sich heute den ganzen Tag gut gehalten. Das war gerade ein kleiner Baer Raid wegen einem Motley Fool Artikel. Am Donnertag wissen wir alle mehr.

    Hot Pharma Stocks / Ideen / Blockbuster

    sharewatch wrote:

    Quote
    Aurum

    Die Verwässerung ist bereits am Freitag bekannt geworden. ASTM hat sich heute den ganzen Tag gut gehalten. Das war gerade ein kleiner Baer Raid wegen einem Motley Fool Artikel. Am Donnertag wissen wir alle mehr.


    Was versprichst Du dir von ASTM? Die Bude hat in den letzten Tagen einen recht steilen Anstieg hinter sich, hoffe für dich es geht so weiter aber mit diesen Verwässerungen ist nicht zu Spassen :(